Nasal Natural Killer-Cell lymphoma: A disease with very poor prognosis

Clinical Oncology

Volumn 12, Issue 5, 2000, Pages 295-297

  Mikhaeel, N G ^a   Spittle, M F ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Lymphoma; Nasal lymphoma; Natural killer cell; Prognosis

Indexed keywords

ANTIBIOTIC AGENT; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CREATININE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LACTATE DEHYDROGENASE; MORPHINE; PREDNISOLONE; UREA; VINCRISTINE;

ADULT; ARTICLE; ASIAN; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CASE REPORT; CAUCASIAN; CELLULITIS; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; EDEMA; FEBRILE NEUTROPENIA; HEMORRHOID; HUMAN; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOMA; MALE; MUCOSA INFLAMMATION; NATURAL KILLER CELL; NEUTROPENIA; NOSE CANCER; PANCYTOPENIA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033693248     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2000.9177     Document Type: Article

References (13)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
2. Kwong YL, Chan AC, Liang RH. Natural killer cell lymphoma/leukemia: pathology and treatment. Hematol Oncol 1997;15:71-9.
3. Chiang AK, Chan AC, Srvastava G, et al. Nasal T/natural killer (NK)-cell lymphomas are derived from Epestein-Barr virus-infected cytotoxic lymphocytes of both NK-and T-cell lineage. Int J Cancer 1997;73:332-8.
4. Jaffe ES, Krenacs L, Kumar S, et al. Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol 1999;111(1 Suppl 1):S46-S55.
5. Siu LL, Wong KF, Chan JK, et al. Comparative genomic hybridization analysis of natural killer cell lymphoma/ leukemia: recognition of consistent pattern of genetic alterations. Am J Pathol 1999;155:1419-25.
6. Wong KF, Zhang YM, Chan JK. Cytogenetic abnormalities in natural killer cell lymphoma/leukemia - is there a consistent pattern? Leuk Lymphoma 1999;34:241-50.
7. Chan JK, Tsang WY, Hui PK, et al. T- and T/natural killer-cell lymphomas of salivary gland: a clinicopathologic, immunohistochemical and molecular study of six cases. Hum Pathol 1997;28:238-45.
8. Martin AR, Chan WC, Perry DA, et al. Aggressive natural killer cell lymphoma of the small intestine. Mod Pathol 1995;8:467-72.
9. Chan JK, Tsang WY, Lau WH, et al. Aggressive T/natural killer cell lymphoma presenting as a testicular tumour. Cancer 1996;77:1198-205.
10. Kwong YL, Chan AC, Liang R, et al. CD56+ NK lymphomas: clinicopathological features and prognosis. Br J Haematol 1997;97:821-9.
11. Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995;13:666-70.
12. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumour immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998;16:70-7.
13. Liang R, Chen F, Lee CK, et al. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant 1997;19:91-3.